Active pharmaceutical ingredients

12-Jan-2021

Surfachem looks at pharmaceutical macro trends and beyond distribution

Pharmaceutical macro trends

High Covid-19 patients requiring hospitalisation may result in an on-going drive to keep other patient conditions managed in a home environment
GP consultation and diagnosis undertaken remotely likely to become the default method
Further development of the home-diagnostic / self-medication sectors
Stay at home culture driving a change in habits

Source: Mintel

Beyond distribution

Surfachem strives to make the difference. Supporting customers beyond supply, Surfachem provides:

GDP compliant (MHRA audited) / API Certified (FMD) / ISO 9001 certified
APIs only from fully GMP-approved sources and thorough due-diligence applied
Secure and transparent GMDP supply chains
Experts in API approvals, regulatory/quality documentation assessments
All volumes supplied (R&D, pilot production, commercial quantities)
Global freight and transportation management to multiple end-user sites

Have you tried?

Through an extensive network of suppliers, Surfachem supplies its customers with an extensive range of active ingredients for their current portfolio and new product development requirements. Aiming to provide a full package of regulatory and quality documentation to support APIs, Surfachem is proud to offer its customers relevant and specific product and market information.

The below active ingredients are distributed by Surfachem with CEP/EDMF and EU-GMP certification.